Katalin Karikó

In 1995, Katalin Karikó was told she wasn’t faculty material.

Her grant proposals were rejected.

Her mRNA research?

Labeled “fanciful” by senior scientists.

The University of Pennsylvania stripped her title and denied her tenure. Most would’ve quit.

She doubled down.

For decades, Katalin pursued a radical idea: that messenger RNA (long dismissed as unstable and impractical) could be the key to treating disease.

She spent years in obscurity, fighting to stay in the lab while others advanced their careers.

Then came the breakthrough.

In 2005, alongside collaborator Drew Weissman, she discovered how to tweak mRNA just enough to silence the body’s immune alarm.

Unlocking a way to safely use it in vaccines and therapies.

Her paper was rejected by Nature and Science.

But it became the foundation of something bigger than peer review.

When COVID-19 emerged in 2020, it was Karikó’s discovery that made the Pfizer-BioNTech and Moderna vaccines possible.

Her science didn’t just save lives.

It changed the future of medicine.

In 2023, she won the Nobel Prize.

In 2024, she donated her winnings to the Hungarian university that believed in her when no one else would.